α-Melanocyte-stimulating hormone in normal human physiology and disease states

Trends in Endocrinology and Metabolism

Volumn 11, Issue 8, 2000, Pages 304-308

  Catania, Anna ^a   Airaghi, Lorena ^a   Colombo, Gualtiero ^a   Lipton, James M ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Zengen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CLONIDINE; CYTOKINE; DOPAMINE; ENDOTOXIN; ISOPRENALINE; PROPRANOLOL;

ACUTE HEART INFARCTION; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; DISEASE SEVERITY; HEMODIALYSIS; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOPHYSIS; MULTIPLE SCLEROSIS; NEUROENDOCRINOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS;

EID: 0033803235     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(00)00296-4     Document Type: Review

References (59)

1. α-Melanocyte stimulating hormone in the modulation of host reactions
2. Anti-inflammatory actions of the neuroimmunomodulator α-MSH
3. Anti-inflammatory effects of the neuropeptide α-MSH in acute, chronic, and systemic inflammation
4. Antimicrobial effects of α-MSH peptides
5. Implications of proopiomelanocortin (POMC) mutations in humans: The POMC deficiency syndrome
6. α-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line
7. A potential mechanism of local anti-inflammatory action of α-MSH peptides within the brain: Modulation of TNFα production by human astrocytic cells
8. Adrenocorticotropin-like and α-melanotropin-like peptides in a subpopulation of human gastrin cell granules: Bioassay, immunoassay, and immunocytochemical evidence
9. Production of immunosuppressing melanotropins by human keratinocytes
10. The neuropeptide α-MSH in HIV infection and other disorders in humans
11. Resuscitating effect of melanocortin peptides after prolonged respiratory arrest
12. The neuropeptide α-MSH inhibits experimental arthritis in rats
13. α-MSH modulates experimental inflammatory bowel disease
14. α-MSH modulates local and circulating tumor necrosis α in experimental brain inflammation
15. The cloning of a family genes that encode the melanocortin receptors
16. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides
17. The central melanocortin system and energy homeostasis
18. Evidence for the differential expression of functional α-melanocyte-stimulating hormone receptor MC1 in human monocytes
19. α-MSH and its receptor in regulation of tumor necrosis factor-α production by human monocyte/ macrophages
20. The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro
21. Animals under the sun: Effects of ultraviolet radiation on mammalian skin
22. α-MSH and the regulation of melanocyte function
23. Human microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with α-melanocyte stimulating hormone
24. Targeted disruption of the melanocortin-4 receptor results in obesity in mice
25. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans
26. Exocrine gland dysfunction in MC5-R-deficient mice: Evidence for coordinated regulation of exocrine gland function by melanocrtin peptides
27. Mechanisms of anti-inflammatory action of the neuroimmunomodulatory peptide α-MSH
28. α-Melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa-B activation induced by various inflammatory agents
29. α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBa degradation in human glioma cells and in experimental brain inflammation
30. Inhibition of peripheral NF-κB activation by central action of α-melanocyte-stimulating hormone
31. α-Melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes
32. Dexamethasone facilitates α-MSH release in the rabbit
33. Immunoreactive alpha-MSH in human plasma in pregnancy
34. Beta-endorphin-like and alpha-MSH-like immunoreactivities in human milk
35. The main immunoreactive alpha-melanocyte-stimulating hormone (alpha MSH)-like substance found in human fetal pituitary tissue is not alpha MSH but may be desacetyl alpha MSH (adrenocorticotropin1-13NH2)
36. Demonstration of desacetyl alpha-melanocyte-stimulating hormone in fetal and adult human anterior pituitary corticotrophs
37. α-Melanocyte-stimulating hormone during human perinatal life
38. Adrenergic regulation of α-MSH secretion in man: Evidence for a stimulatory role of beta-receptors
39. Clonidine lowers α-MSH-like immunoreactivity in human plasma
40. Effect of various dopaminergic and antidopaminergic drugs and TRH on plasma α-melanocyte-stimulating hormone concentrations in adult man
41. Endotoxin causes α-MSH release in normal subjects
42. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia
43. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone
44. Proopiomelanocortin-derived peptides and cytokines: Relations in patients with acquired immunodeficiency syndrome
45. Elevated concentrations of plasma α-melanocyte stimulating hormone are associated with reduced disease progression in HIV-infected patients
46. Melanocortin peptides inhibit production of proinflammatory cytokines in blood of HIV-infected patients
47. Plasma concentrations and anti-cytokine effects of α-melanocyte stimulating hormone in septic patients
48. The anticytokine neuropeptide α-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: Comparisons with other anticytokine molecules
49. Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy
50. The neuropeptide α-MSH in multiple sclerosis. Second Research Project on Multiple Sclerosis
51. Elevated concentrations of circulating α-MSH in patients on chronic hemodialysis
52. α-Melanocyte-stimulating hormone-like immunoreactivity is increased in patients with Parkinson's disease
53. Extrahypophyseal distribution of α-melanocyte stimulating hormone (α-MSH)-like immunoreactivity in postmortem brains from normal subjects and Alzheimer type dementia patients
54. Thyrotropin-releasing hormone (TRH) selectively binds and activates the melanocortin 1 receptor
55. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin
56. Antimicrobial peptides of phagocytes and epithelia
57. Modulation of inflammatory effects of cytokines by the neuropeptide α-MSH
58. Modulation of ICAM-1 expression by α-MSH in human melanoma cells and melanocytes